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The renin-angiotensin system has been implicated in regulating
renal medullary and papillary microcirculation and urinary con-
centrating processes, but the mechanisms by which angiotensin II
(Mg II) exerts its influences in the renal medulla are not well
understood [1]. Although physiological studies demonstrated that
medullary blood flow and/or papillary blood flow may be altered
by dietary sodium intake [1], inhibition of Mg II formation by
angiotensin converting enzyme inhibitors [2], and infusion of
exogenous Mg II with or without blockade of Mg II receptors [3,
4], controversy remains with respect to whether Mg II directly or
indirectly exerts its influences on renal medullary processes.
Because the cortical and medullary vasculatures display different
sensitivities to Ang II [4, 5], cortical and medullary blood flow may
be independently regulated by different mechanisms. In the renal
medulla, both circulating and intrarenal Mg II may act indepen-
dently, or interact with other circulating vasoactive peptides and
local humoral paracrine factors, such as atrial natriuretic peptide,
endothelin, the kallikrein-kinin system, prostaglandins and nitric
oxide, to regulate microcirculation and urinary concentrating and
diluting processes. In view of the importance of Mg II in regulating
renal medullary function, and in order to help elucidate the mecha-
nisms of the actions of Mg II in the renal medulla, this article will
review the localization and regulation of Mg II receptors in the
renomedullary interstitial cells in the renal medulla.
Cellular localization of Ang II receptors in type 1
renomedullary interstitial cells
Our in vitro autoradiographic studies consistently show a very
high density of Mg II receptors in the inner stripe of the outer
medulla of the kidney in several species including rat, rabbit,
guinea pig, monkey, and human [6, 7]. Since the inner stripe of the
outer medulla comprises the vasa recta bundles, the renal tubules
including the limbs of loop of Henle, outer medullary collecting
duct, and the interstitium, it has been speculated that each of
these structures might bear Mg II receptors. Indeed, a study of
microdissected nephron segments demonstrated Ang II receptor
binding not only in proximal tubule, a well established site, but
also in other less-defined tubular segments, such as the loop of
Henle, distal tubule, and collecting duct [8]. More recently,
mRNA for AT1 receptors [9] and immunoreactive AT1 protein
[10] have been localized in thick ascending limb epithelium or the
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vasa recta [11]. These patterns in renal distribution of AT1
receptor mRNA expression or immunoreactive AT1 receptor
protein contrast markedly with our electron microscope autora-
diographic localization of Mg II receptors in the inner stripe of
the outer medulla [12].
The disparity between autoradiographic localization of Mg II
receptor binding sites and immunohistochemical or molecular
localization of Ang II receptor mRNA expression may be due to
either tissue preparation [10] or post-transcriptional regulation of
gene expression [9]. Instead of using frozen tissue sections, in our
study, fresh tissue blocks from the inner stripe of the outer
medulla of the rat kidney were incubated with 1251-[Sar1,11e8j Mg
II in Krebs buffer saturated with 95% 02: 5% C02, washed, fixed
with glutaraldehyde, and processed as described for electron
microscope autoradiography [12]. Light microscopic autoradiog-
raphy showed a high density of Mg II receptor binding in the
inner stripe, where silver grains outlined renal tubules and the vasa
recta bundles. Cellular identification of Mg II binding was con-
firmed by electron microscopy, with silver grain distribution almost
exclusively in the type 1 renomedullary interstitial cells (RMICs),
situated between the vasa rectae and renal tubules (Fig. 1A). No
binding was detected over the cells of the descending thin limb and
ascending thick limb of the loop of Henle, the medullary collecting
duct, or the vasa rectae (Fig. 1A). Therefore, our study suggests that
the type 1 RMICs are the primary sites for Mg II receptors.
In vivo regulation of Ang II receptors in type 1 renomedullary
interstitial cells
We have recently demonstrated a striking difference in renal
distribution of Ang II receptor binding in the rat kidney following
in vitro and in vivo labeling [13]. Although Mg II receptor binding
in glomeruli and proximal tubules was similar by both techniques,
binding in the inner stripe as revealed in the in vitro autoradio-
graphs was completely absent after systemically administered
'25I-Ang II or its radiolabeled antagonist analogue, 1251-[Sar1,Ile8]
Mg II, These observations indicate that Mg II receptor binding
sites in type 1 RMICs in the inner stripe are not readily labeled by
the vascularly delivered radioligands. We considered that either
reduced vascular delivery due to Mg Il-induced renal vasocon-
striction, or alternatively prior occupancy of these sites by endo-
genous Ang II, might explain the difference between in vitro and
in vivo localization of Mg II receptors in the kidney.
We have investigated these hypotheses by using electron mi-
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logue, '251-[Sar1,11e8] Ang II, did not alter binding to the inner
stripe. By contrast, chronic salt-loading (Fig. 1B) or inhibition of
ACE with perindopril, 5 mg/kg/day for one week (Fig. 1C),
significantly increased Ang II receptor binding to the type 1
RMICs in vivo. These findings suggest that in vivo occupancy of Mg
II receptor binding sites in the inner stripe of the outer medulla by
endogenous Ang II is the most likely explanation of the striking
difference between in vitro and in vivo labeling of Mg II receptors in
the renal medulla, rather than the hemodynamic effects.
In vivo blockage of AT1 receptors in the renal medulla
Mg II receptors in type 1 RMICs of the inner stripe of the
outer medulla are not readily labeled by systemically delivered
radioligands in vivo [14], but they can be effectively blocked by the
AT1 receptor antagonist, losartan, following oral [14] and intra-
venous administration [15]. In the rat kidney, we have observed a
dose- and time-dependent inhibition of Mg II receptor binding in
the inner stripe following intravenous administration of losartan.
At 10 mg/kg, Mg II receptor binding was completely inhibited,
and this inhibition sustained as long as 24 hours after administra-
tion. Similarly, in rats receiving losartan in drinking water for one
week (5 mg/kg/day), 1251-Mg II binding was also completely
abolished in vivo [15]. These findings therefore suggest that AT1
receptors in type 1 RMICs are readily accessible to systemically
delivered losartan under physiological conditions.
Fig. 1. Electron microscope autoradiographic localization of Ang II recep-
tors in type I renomedullaty interstitial cells (RMICs) in the inner stripe of the
outer medulla of rat kidney. (A) In vitro labeling of Ang II receptors in fresh
tissue blocks which were taken from the inner stripe and incubated with
'251-[Sar1,11e8] Ang II (magnification: >C 7200). (B) In vivo labeling of Ang
II receptors following systemically administered '251-Ang II in a rat given
1% NaCl solution for one week (magnification: x 7300). (C) In vivo
labeling of Mg II receptors following systemically administered 1251-Mg
II in a rat pretreated with perindopril (5 mg/kg/day) for one week
(magnification: X 7000). Silver grains were detected primarily in type 1
RMICs either by in vitro or in viva labeling techniques after chronic
salt-loading and ACE inhibition. Stain: Uranyl acetate, lead citrate.
Abbreviations arc: DT, distal tubules; CD, collecting ducts; IC, renomed-
ullary interstitial cells; C, peritubular capillary.
the inner stripe in anaesthetized rats pre-treated with either a
vasodilator, or high salt intake, or an angiotensin converting
enzyme (ACE) inhibitor [14]. Our results indicate that the
absence of Mg II receptor binding in the inner stripe following
systemically administered radioligands was not due to Mg II-
induced renal vasoconstriction, since prior renal vasodilatation
induced by sodium nitroprusside, or use of the antagonist ana-
Localization of Ang II receptors in cultured renomedullnry
interstitial cells
Although a high density of Mg II receptor binding occurs in
type 1 RMICs in the inner stripe of the outer medulla, its
physiological role in renal medullary microcirculation and tubular
function is currently unknown. Since it is difficult to gain access to
these cells in vivo, cultured renomedullary interstitial cells provide
a useful preparation for studying cellular mechanisms of physio-
logic responses to stimulation of Mg H receptors in the renal
medulla. We have therefore cultured type 1 renomedullary inter-
stitial cells from rat renal medulla including the inner stripe and
the inner medulla using the methods described by Fontoura et al
[16]. Transmission electron microscopy was used to characterize
the morphology of the cultured RMICs, and emulsion autoradio-
graphic localization of Mg II receptor binding was performed.
For this purpose, confluent monolayers of cultured RMICs grown
in multi-well plates (1 X 106 cells/well) [16] were incubated in
normal salt balance culture medium containing 0.2 1iCi/ml of
1251-[Sar',11e8] Mg II for one hour at 22°C, washed by 4 X 1
minute in fresh, cold medium, and then fixed in 2.5% glutaralde-
hyde in 0.1 M sodium phosphate buffer, pH 7.3, at 22°C for one
hour. The cultured RMICs were then dipped into LM-1 liquid
emulsion (Amersham, UK), and exposed for three weeks in
light-tight cassettes with silica gel. After exposure, the sections
were developed in Kodak D19 developer, dried and counter-
stained with hematoxylin and eosin for high resolution localiza-
tion of Mg II receptor binding. Figure 2A shows high densities of
specific Mg II receptor binding overlying the cultured RMICs.
This binding could be largely displaced by an excess (1 jiM) of
unlabeled Mg II (Fig. 2B). Our autoradiographic localization of
Mg II receptor binding in cultured RMICs confirms the presence
of high density, high-affinity Mg II receptor binding sites in these
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Fig. 2. Autoradiographic localization of Ang II receptor binding in cultured
renomedullaiy interstitial cells (RMICs). Confluent monolayers of cultured
RMICs were incubated in normal tissue culture medium containing
'I-[Sar1,Ile8] Ang II alone (total binding, A), or in the presence of an
excess concentration of unlabeled Ang 11(1 IM) to determine non-specific
binding (B). Silver grains (arrows) were seen overlying a cultured RMIC
(A), but were largely displaced by 1 JLM of unlabeled Ang 11(B).
Magnification: X 625. Stain: hematoxyhin and eosin.
Concluding remarks
AT1 receptors have been localized in type 1 RMICs in the inner
stripe of the outer medulla by electron microscopic autoradiog-
raphy following in vitro and in vivo labeling, and in cultured
RMICs. Aug II receptor binding sites in RMICs appear to be
readily labeled in vitro by the radioligand, but not in vivo following
systemic radioligand administration. However, in vivo labeling of
Aug II receptors in these cells can be enhanced by chronic
salt-loading and ACE inhibition, but not by renal vasodilatation or
an antagonist radioligand. Considering the presence of high
concentrations of renin, angiotensinogen, and Aug II in renal
lymph [18], and in other fluid compartments of the kidney [19], a
new hypothesis may be proposed from our observations. The Aug
II receptor-bearing RMICs are more likely to be responsive to
intrarenal interstitial Aug II rather than to the circulating hor-
mone, and Aug II may therefore have important paracrine and/or
autocrine influences on the renomedullary interstitial cells. The
consequences of Aug II stimulation of these cells are currently
under investigation. They may indirectly influence the renal
medullary microcirculation and urinary concentrating processes,
or tubular function. Given the finding of receptors and signal
transduction pathways also for ANP and endothehin on RMICs
[16, 201, and the ability of RMICs to synthesize and release
prostaglandins [17] and medulhipins [21], interactions between
vasoactive peptides and lipids may play an important role in
physiological control of renal medullary function, and in patho-
physiology of hypertensive states.
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